mevalonolactone has been researched along with Fibrosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, YY; Chen, MH; Ge, MX; He, HW; Li, Y; Li, YM; Lu, ZN; Niu, WX; Zhang, N | 1 |
1 other study(ies) available for mevalonolactone and Fibrosis
| Article | Year |
|---|---|
Dehydromevalonolactone ameliorates liver fibrosis and inflammation by repressing activation of NLRP3 inflammasome.
Topics: Animals; Fibrosis; Humans; Inflammasomes; Inflammation; Liver; Liver Cirrhosis; Mevalonic Acid; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Non-alcoholic Fatty Liver Disease; Rats | 2022 |